The Canadian Association of Pharmacy in Oncology (CAPhO) is a member-directed association that promotes, supports, and advances oncology pharmacy practice to improve the lives of people affected by cancer in Canada. CAPhO’s Vision is to be the leader in advancing oncology pharmacy in Canada. As a recognized authority in the field, CAPhO brings together pharmacists, pharmacy technicians, assistants, and students who are committed to the highest standards of oncology pharmacy care. CAPhO supports the provision of safe and effective oncology pharmacy services through mentorship, education, research, and professional development. CAPhO advocates for excellence in oncology pharmacy by fostering collaboration and engagement with healthcare providers, patients, and other organizations.

Learn more about CAPhO through our website, social media platforms, and our "about" page, and become a member today.

Latest News & Updates

Canada’s Drug Agency seeks 4 members for our Appropriate Use Advisory Committee (AUAC). AUAC is a forum to share information, enhance capacity, support collaboration, and provide advice to address the appropriate use of medications across Canada. Apply by March 30.

Canada’s Drug Agency seeks 2 expert members for our Formulary Management Expert Committee (FMEC). FMEC issues drug reimbursement recommendations to the participating public drug programs and cancer agencies (except Quebec). FMEC also trials innovative approaches to health technology assessment. Apply by March 30.

Canada’s Drug Agency seeks up to 1 expert member for our pan-Canadian Oncology Drug Review Expert Review Committee (pERC). pERC issues reimbursement recommendations for oncology drugs to the participating public drug programs and cancer agencies (except Quebec). Apply by March 30.